While eyes have been on China for signs that COVID-19 might result in drug shortages, India has come up with a surprise of its own. The country, which accounts for about 40% of U.S. generic drugs, has halted exports of more than two dozen APIs and drugs. India’s Directorate General of Foreign Trade today announced… Read More »
The proliferation of fake medicines in Africa is a public health crisis that can no longer be ignored, according to a UK charity. There’s a meeting of seven African countries, in Togo, this week, to combat the problem. Congo, Niger, Senegal, Togo, Uganda, Ghana and The Gambia will discuss measures to clamp down on trafficking… Read More »
ORLANDO, Fla., Jan. 6, 2020 /PRNewswire/ — AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., is pleased to include Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), a new breakthrough therapy for cystic fibrosis (CF), among other specialty medications available through its pharmacy. Cystic fibrosis is a rare, progressive, life-threatening disease… Read More »
In 1992, a University of Rochester pharmacologist named Michael Weintraub published a study on a drug combination that appeared to produce never-before-seen weight loss. By week 34, his subjects — 121 volunteers — lost, on average, 30 pounds. What’s more, they rated the fenfluramine-plus-phentermine regimen not only more helpful than placebo, but also not terribly “bothersome.” The tiny study… Read More »
Valisure: “Valisure Citizen Petition on Ranitidine.” Sandoz Inc.: “Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product.” Bloomberg: “Carcinogen in Zantac Leads to Another Shipment Halt, Recall.” Health Canada: “Health Canada requests that companies stop distributing ranitidine drugs in… Read More »